Investigating the PTSNtr in Pseudomonas aeruginosa
In plain English
AI plain-English summaryThe bacterium *Pseudomonas aeruginosa* switches into a dormant, slow-growing state during infection, making it stubbornly resistant to antibiotics. This project targets a three-protein signalling system called PTSNtr that controls the bacterium’s behaviour in that dormant state. Current antibiotics mostly kill actively growing bacteria, so infections caused by dormant *P. aeruginosa*—common in cystic fibrosis patients and chronic wounds—are notoriously difficult to treat. The PTSNtr system is poorly understood, and no existing drugs target it. The researcher will first identify which proteins interact with the system’s key component, PtsN, then build bacterial strains missing parts of the system to see how signalling changes under infection-like conditions, such as nutrient scarcity and immune cell attack. Finally, they will screen compound libraries for drugs that disrupt PTSNtr signalling, aiming to make dormant bacteria vulnerable to existing antibiotics. If successful, this work could reveal a new way to sensitise *P. aeruginosa* to antibiotics without developing entirely new drugs. Because the PTSNtr system is widespread among bacteria, understanding its fundamental biology might also inform strategies against other hard-to-treat infections. The project is primarily curiosity-driven fundamental science, but its focus on disrupting a specific signalling pathway has clear translational potential.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
PhD Studentship (Basic)Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know